spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

9th Global Drug Delivery & Formulation Summit

Global Drug Delivery & Formulation Summit 2018

12-14 March 2018
Maritim proArte Hotel Berlin

The growth of biopharma, patient compliance issues and ever increasing regulatory requirements have encouraged us to adopt a drug delivery mind set from discovery through to production.

Every year we see innovation and breakthroughs at all levels of drug and formulation development. From big pharma, through the smaller biotechnology companies all the way to university research teams and spin outs.

The DDF Summit brings the most interesting studies and exciting technologies to you. This year there will be 4 dedicated streams focusing on Small Molecules, Biologics, Technology & Innovation and for the first-time Device Development.

You’ll find new technologies, concepts and case studies in areas such as…

 Less traditional delivery routes including nasal, ocular & subcutaneous

 Targeted and controlled release technologies and nanoparticles

 Increasing stability of amorphous solid dispersion

 QbD in biopharmaceutical development

 Formulation strategies for multiple injection dosing

 Oral delivery of peptides

 Continuous manufacturing and processing for improved efficiency

 User friendly technologies for improving patient convenience and compliance

 Regulatory strategies for combination products

 Drug stability and material selection in combination products

Visit www.ddfevent.comor contact maxconferences@markallengroup.comfor more information.

phone +44 (0)20 7738 5454
email maxconferences@markallengroup.com
web www.ddfevent.com
email Maritim proArte Hotel Berlin
 
Print this page
Send to a friend
   
spacer
Industry Events

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018, Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking.
More info >>

Banner of PHPL West Coast_events_95 on Samedan Banner of Nordics_Events_97 on Samedan

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>


News and Press Releases

BioIVT Acquires Optivia Biotechnology, Adding Transporter Assay Products and Services to its ADME-Tox Portfolio

BioIVT, a leading provider of research models and services for drug development, today announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems biology, and molecular transport research solutions.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement